261 Note 30.17 Segment information (continued) b) Operating segment (` cr) Particulars Life Science Chemicals Performance and Other Chemicals Others Total 2022-23 2021-22 2022-23 2021-22 2022-23 2021-22 2022-23 2021-22 i) Segment revenue Gross sales 1,959.16 1,465.10 3,706.17 3,759.18 49.64 69.98 5,714.97 5,294.26 Less: Inter-segment revenue 0.29 0.44 287.16 212.93 - - 287.45 213.37 Net revenue from operations 1,958.87 1,464.66 3,419.01 3,546.25 49.64 69.98 5,427.52 5,080.89 ii) Segment results Profit before finance cost and tax 422.65 178.88 240.25 575.89 1.15 24.43 664.05 779.20 Less: Finance costs 7.90 9.17 Less: Other unallocable expenditure (net of unallocable income) (27.86) (31.55) Add: Share of net profit of joint venture company 3.83 8.16 Profit before tax 687.84 809.74 iii) Other information Segment assets 1,310.18 1,199.03 3,280.99 2,904.22 195.02 162.49 4,786.19 4,265.74 Unallocated common assets 981.79 1,440.61 Total assets 5,767.98 5,706.35 Segment liabilities 266.43 284.69 559.24 652.11 31.24 47.36 856.91 984.16 Unallocated common liabilities 191.65 262.35 Total liabilities 1,048.56 1,246.51 Additions to assets and intangible assets 311.00 105.85 602.18 524.12 0.73 6.79 913.91 636.76 Unallocated additions to assets and intangible assets - 3.69 Total capital expenditure* 913.91 640.45 Depreciation 47.65 45.96 141.98 123.05 4.59 4.12 194.22 173.13 Unallocated depreciation 3.59 3.56 Total depreciation 197.81 176.69 c) Geographical segment (` cr) Particulars In India Outside India Total 2022-23 2021-22 2022-23 2021-22 2022-23 2021-22 Segment revenue 2,867.95 2,525.88 2,559.57 2,555.01 5,427.52 5,080.89 Carrying cost of assets by location of assets 5,482.68 5,343.32 285.30 363.03 5,767.98 5,706.35 Additions to assets and intangible assets* 905.75 640.45 8.16 - 913.91 640.45 *Including capital work-in-progress and capital advances
RkJQdWJsaXNoZXIy MjA2MDI2